drug message or purpose intended to re-
duce drug use; 
‘‘(v) requests funding for drug treat-
ment activities that do not adequately sup-
port and enhance Federal drug treatment 
programs and capacity; 
‘‘(vi) requests funding for fiscal year 
2007 for activities of the Department of 
Education, unless it is accompanied by a 
report setting forth a plan for providing 
expedited consideration of student loan ap-
plications for all individuals who submitted 
an application for any Federal grant, loan, 
or work assistance that was rejected or de-
nied pursuant to 484(r)(1) of the Higher 
Education 
Act 
of 
1965 
(20 
U.S.C. 
1091(r)(1)) by reason of a conviction for a 
drug-related offense not occurring during a 
period of enrollment for which the indi-
vidual was receiving any Federal grant, 
loan, or work assistance; and 
‘‘(vii) requests funding for the oper-
ations and management of the Department 
of Homeland Security that does not in-
clude a specific request for funds for the
Office of Counternarcotics Enforcement to 
carry out its responsibilities under section 
878 of the Homeland Security Act of 2002 
(6 U.S.C. 458).’’; 
(3) in subparagraph (D)(iii), as so redesig-
nated, by inserting ‘‘and the appropriate congres-
sional committees’’ after ‘‘House of Representa-
tives’’; and 
(4) in subparagraph (E)(ii)(II)(bb), as so redes-
ignated, by inserting ‘‘and the appropriate congres-
sional committees’’ after ‘‘House of Representa-
tives’’. 
(d) REPROGRAMMING AND TRANSFER REQUESTS.—
Section 704(c)(4)(A) (21 U.S.C. 1703(c)(4)(A)) is amend-
ed—
(1) by striking ‘‘$5,000,000’’ and inserting 
‘‘$1,000,000’’; and 
(2) adding at the end the following: ‘‘If the Di-
rector has not responded to a request for reprogram-
ming subject to this subparagraph within 30 days 
after receiving notice of the request having been 
made, the request shall be deemed approved by the 
Director under this subparagraph and forwarded to 
Congress.’’.
(e) POWERS
OF
DIRECTOR.—Section 704(d) is 
amended—
(1) in paragraph (8)(D), by striking ‘‘have been 
authorized by Congress;’’ and inserting ‘‘authorized 
by law;’’; 
(2) in paragraph (9), by striking ‘‘Strategy; 
and’’ and inserting ‘‘Strategy and notify the appro-
priate congressional committees of any fund control 
notice issued; and’’; and 
(3) in paragraph (10), by striking ‘‘(22 U.S.C. 
2291j).’’ and inserting ‘‘(22 U.S.C. 2291j) and sec-
tion 706 of the Foreign Relations Authorization Act, 
Fiscal Year 2003 (22 U.S.C. 2291j–1).’’. 
(f) FUND CONTROL NOTICES.—Section 704(f) (21 
U.S.C. 1703(f)) is amended by adding at the end the fol-
lowing: 
‘‘(4) CONGRESSIONAL NOTICE.—A copy of each 
fund control notice shall be transmitted to the ap-
propriate congressional committees. 
‘‘(5) RESTRICTIONS.—The Director shall not 
issue a fund control notice to direct that all or part 
of an amount appropriated to the National Drug 
Control Program agency account be obligated, modi-
fied, or altered in any manner contrary, in whole or 
in part, to a specific appropriation or statute.’’.
TITLE II—THE NATIONAL DRUG 
CONTROL STRATEGY 
SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NA-
TIONAL DRUG CONTROL STRATEGY. 
Section 706 is amended to read as follows: 
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL-
OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL 
STRATEGY.—
‘‘(1) TIMING.—Not later than February 1 of 
each year, the President shall submit to Congress a 
National Drug Control Strategy, which shall set 
forth a comprehensive plan for the year to reduce il-
licit drug use and the consequences of such illicit 
drug use in the United States by limiting the avail-
ability of, and reducing the demand for, illegal 
drugs. 
‘‘(2) CONTENTS.—
‘‘(A) IN
GENERAL.—The National Drug 
Control Strategy submitted under paragraph 
(1) shall include the following: 
‘‘(i) Comprehensive, research-based, 
long-range, quantifiable goals for reducing
illicit drug use and the consequences of il-
licit drug use in the United States. 
‘‘(ii) Annual quantifiable and measur-
able objectives and specific targets to ac-
complish long-term quantifiable goals that 
the Director determines may be achieved 
during each year beginning on the date on 
which the National Drug Control Strategy 
is submitted. 
‘‘(iii) A 5-year projection for program 
and budget priorities. 
‘‘(iv) A review of international, State, 
local, and private sector drug control ac-
tivities to ensure that the United States 
pursues coordinated and effective drug 
control at all levels of government. 
‘‘(v) An assessment of current illicit 
drug use (including inhalants and steroids) 
and availability, impact of illicit drug use, 
and treatment availability, which assess-
ment shall include—
‘‘(I) estimates of drug prevalence 
and frequency of use as measured by 
national, State, and local surveys of il-
licit drug use and by other special
studies of nondependent and depend-
ent illicit drug use; 
‘‘(II) illicit drug use in the work-
place and the productivity lost by such 
use; and 
‘‘(III) 
illicit 
drug 
use 
by 
arrestees, probationers, and parolees. 
‘‘(vi) An assessment of the reduction 
of illicit drug availability, as measured 
by—
‘‘(I) the quantities of cocaine, 
heroin, marijuana, methamphetamine, 
ecstasy, and other drugs available for 
consumption in the United States; 
‘‘(II) the amount of marijuana, 
cocaine, heroin, methamphetamine, ec-
stasy, and precursor chemicals and 
other drugs entering the United 
States; 
‘‘(III) the number of illicit drug 
manufacturing laboratories seized and 
destroyed and the number of hectares 
of marijuana, poppy, and coca cul-
tivated and destroyed domestically 
and in other countries;
‘‘(IV) the number of metric tons 
of marijuana, heroin, cocaine, and 
methamphetamine seized and other 
drugs; and 
‘‘(V) changes in the price and 
purity of heroin, methamphetamine, 
and cocaine, changes in the price of 
ecstasy, 
and 
changes 
in 
tetrahydrocannabinol level of mari-
juana and other drugs. 
‘‘(vii) An assessment of the reduction 
of the consequences of illicit drug use and 
availability, which shall include—
‘‘(I) the burden illicit drug users 
placed on hospital emergency depart-
ments in the United States, such as 
the quantity of illicit drug-related 
services provided; 
‘‘(II) the annual national health 
care cost of illicit drug use; and 
‘‘(III) the extent of illicit drug-
related crime and criminal activity. 
‘‘(viii) A determination of the status 
of drug treatment in the United States, by 
assessing—
‘‘(I) public and private treatment 
utilization; and 
‘‘(II) the number of illicit drug 
users the Director estimates meet di-
agnostic criteria for treatment. 
‘‘(ix) A review of the research agenda 
of the Counterdrug Technology Assessment 
Center to reduce the availability and abuse 
of drugs. 
‘‘(x) A summary of the efforts made 
to coordinate with private sector entities to 
conduct private research and development 
of medications to treat addiction by—
‘‘(I) screening chemicals for po-
tential therapeutic value; 
‘‘(II) developing promising com-
pounds; 
‘‘(III) conducting clinical trials; 
‘‘(IV) seeking Food and Drug 
Administration approval for drugs to 
treat addiction; 
‘‘(V) marketing the drug for the 
treatment of addiction;